Lacroix, A., Gu, F., Schopohl, J., Kandra, A., Pedroncelli, A. M., Jin, L., & Pivonello, R. (2019). Pasireotide treatment significantly reduces tumor volume in patients with Cushing’s disease: Results from a Phase 3 study. Pituitary.

Lacroix, André, Feng Gu, Jochen Schopohl, Albert Kandra, Alberto M. Pedroncelli, Lixian Jin, und Rosario Pivonello. "Pasireotide Treatment Significantly Reduces Tumor Volume in Patients With Cushing’s Disease: Results From a Phase 3 Study." Pituitary 2019.

Lacroix, André, et al. "Pasireotide Treatment Significantly Reduces Tumor Volume in Patients With Cushing’s Disease: Results From a Phase 3 Study." Pituitary 2019.